Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs

Rapid Communications in Mass Spectrometry

Volumn 26, Issue 5, 2012, Pages 499-509

  Henry, Hugues ^a   Sobhi, Hamid Reza ^a,b   Scheibner, Olaf ^c   Bromirski, MacIej ^c   Nimkar, Subodh B ^d   Rochat, Bertrand ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Tehran Payamenoor University   (Iran)

^c THERMO FISHER SCIENTIFIC   (Germany)

^d Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENTS; DRUG PRODUCTS; MASS SPECTROMETERS;

ACCURATE MASS; HIGH RESOLUTION; MASS RESOLUTION; ORBITRAP; PLASMA SAMPLES; SELECTED REACTION MONITORING; SINGLE STAGE; THERAPEUTIC DRUGS; TRIPLE-QUADRUPOLE MASS SPECTROMETER; VORICONAZOLE;

CHROMATOGRAPHIC ANALYSIS;

EID: 84856756316     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6121     Document Type: Article

References (40)

1. B. Shushan,. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom. Rev. 2010, 29, 930.
2. T. R. Covey, E. D. Lee, J. D. Henion,. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples. Anal. Chem. 1986, 58, 2453.
3. N. Zhang, A. Yang, J. D. Rogers, J. J. Zhao,. Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2004, 34, 175.
4. C. M. Chavez-Eng, M. L. Constanzer, B. K. Matuszewski,. Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection. J. Pharm. Biomed. Anal. 2004, 35, 1213.
5. L. A. Leuthold, C. Grivet, M. Allen, M. Baumert, G. Hopfgartner,. Simultaneous selected reaction monitoring, MS/MS and MS3 quantitation for the analysis of pharmaceutical compounds in human plasma using chip-based infusion. Rapid Commun. Mass Spectrom. 2004, 18, 1995.
6. C. Pistos, M. Koutsopoulou, I. Panderi,. A validated liquid chromatographic tandem mass spectrometric method for the determination of mirtazapine and demethylmirtazapine in human plasma: application to a pharmacokinetic study. Anal. Chim. Acta 2004, 514, 15.
7. K. A. Francesconi, S. A. Pergantis,. Application of selected reaction monitoring tandem mass spectrometry to the quantitative determination of an arsenic-containing nucleoside in a crude biological extract. Analyst 2004, 129, 398.
8. H. Hara, T. Uchimura, N. Akashi, T. Naganuma, T. Aizawa, Y. Nagae, N. Masuda,. Simultaneous analytical method for the determination of TCH346 and its four metabolites in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2004, 18, 377.
9. K. Whalen, J. Gobey, J. Janiszewski,. A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening. Rapid Commun. Mass Spectrom. 2006, 20, 1497.
10. D. M. Higton,. A rapid, automated approach to optimisation of multiple reaction monitoring conditions for quantitative bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15, 1922.
11. K. M. Whalen, K. J. Rogers, M. J. Cole, J. S. Janiszewski,. AutoScan: an automated workstation for rapid determination of mass and tandem mass spectrometry conditions for quantitative bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 2000, 14, 2074.
12. N. K. Dube, R. King, D. McLoughlin, G. Adamson, W. B. Emary,. 24th Montreux LC/MS Symposium, Oct. 8-12, Hilton Head Island, SC USA; poster presentation, 2007.
13. R. Coles, M. M. Kushnir, G. J. Nelson, G. A. McMillin, F. M. Urry,. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS. J. Anal. Toxicol. 2007, 31, 1.
14. T. K. Majumdar, S. Vedananda, F. L. Tse,. Rapid analysis of MMI270B, an inhibitor of matrix metalloproteases in human plasma by liquid chromatography-tandem mass spectrometry: matrix interference in patient samples. Biomed. Chromatogr. 2004, 18, 77.
15. A. Kaufmann, P. Butcher, K. Maden, S. Walker, M. Widmer,. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared to tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 979.
16. M. Jemal, Y.-Q. Xia,. The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 1999, 13, 97.
17. B. K. Matuszewski, C. M. Chavez-Eng, M. L. Constanzer,. Development of high-performance liquid chromatography-tandem mass spectrometric methods for the determination of a new oxytocin receptor antagonist (L-368,899) extracted from human plasma and urine: a case for lack of specificity due to the presence of metabolites. J. Chromatogr. 1998, 716, 195.
18. M. Furlong, A. Bessire, W. Song, C. Huntington, E. Groeber,. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples. Rapid Commun. Mass Spectrom. 2010, 24, 1902.
19. W. Lu, M. F. Clasquin, E. Melamud, D. Amador-Noguez, A. A. Caudy, J. D. Rabinowitz,. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal. Chem. 2010, 82, 3212.
20. A. G. Marshall, C. L. Hendrickson,. High-resolution mass spectrometers. Annu. Rev. Anal. Chem. 2008, 1, 579.
21. M. Scigelova, A. Makarov,. Advances in bioanalytical LC-MS using the Orbitrap™ mass analyzer. Bioanalysis 2009, 1, 741.
22. K. P. Bateman, M. Kellmann, H. Muenster, R. Papp, L. Taylor,. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 2009, 81, 1881.
23. B. Shushan,. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom. Rev. 2010, 29, 930.
24. H. H. Maurer,. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal. Bioanal. Chem. 2007, 388, 1315.
25. J. L. Jiwan, P. Wallemacq, M. F. Hérent,. HPLC-high resolution mass spectrometry in clinical laboratory? Clin. Biochem. 2011, 44, 136.
26. Y. Moulard, L. Bailly-Chouriberry, S. Boyer, P. Garcia, M. A. Popot, Y. Bonnaire,. Use of benchtop exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control. Anal. Chim. Acta 2011, 700, 126.
27. N. R. Zhang, S. Yu, P. Tiller, S. Yeh, E. Mahan, W. B. Emary,. Quantitation of small molecules using high-resolution accurate mass spectrometers-a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 2009, 23, 1085.
28. D. Favretto, G. Stocchero, S. Vogliardi, G. Frison, D. Trevisanuto, F. Castagna, S. D. Ferrara,. Neonatal hair analysis by liquid chromatography-high- resolution mass spectrometry to reveal gestational exposure to venlafaxine. Ther. Drug Monit. 2010, 32, 30.
29. S. Vogliardi, D. Favretto, M. Tucci, G. Stocchero, S. D. Ferrara,. Simultaneous LC-HRMS determination of 28 benzodiazepines and metabolites in hair. Anal. Bioanal. Chem. 2011, 400, 51.
30. J. Wang, W. Chow, D. Leung,. Applications of LC/ESI-MS/MS and UHPLC QqTOF MS for the determination of 148 pesticides in fruits and vegetables. Anal. Bioanal. Chem. 2010, 396, 1513.
31. J. Wang, D. Leung, W. Chow,. Applications of LC/ESI-MS/MS and UHPLC QqTOF MS for the determination of 148 pesticides in berries. J. Agric. Food Chem. 2010, 58, 5904.
32. L. N. Williamson, M. G. Bartlett,. Quantitative liquid chromatography/time-of-flight mass spectrometry. Biomed. Chromatogr. 2007, 21, 567.
33. L. N. Williamson, G. Zhang, A. V. Terry Jr, M. G. Bartlett,. Comparison of time-of-flight mass spectrometry to triple quadrupole tandom mass spectrometry for quantitative bioanalysis: application to antipsychotics. J. Liq. Chromatogr. Relat. Technol. 2008, 31, 2737.
34. L. A. Decosterd, B. Rochat, B. Pesse, T. Mercier, F. Tissot, N. Widmer, J. Bille, T. Calandra, B. Zanolari, O. Marchetti,. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. Antimicrob. Agents Chemother. 2010, 54, 5303.
35. N. Ansermot, M. Fathi, J. L. Veuthey, J. Desmeules, S. Rudaz, D. Hochstrasser,. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin. Biochem. 2008, 41, 728.
36. A. Haouala, B. Zanolari, B. Rochat, M. Montemurro, K. Zaman, M. A. Duchosal, H. B. Ris, S. Leyvraz, N. Widmer, L. A. Decosterd,. Therapeutic drug monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. J. Chromatogr. B 2009, 877, 1982.
37. A. Kaufmann, M. Widmer, K. Maden,. Post-interface signal suppression, a phenomenon observed in a single-stage Orbitrap mass spectrometer coupled to an electrospray interfaced liquid chromatography. Rapid Commun. Mass Spectrom. 2010, 24, 2162.
38. R.L. Wong, B. Xin, T. Olah,. Optimization of Exactive Orbitrap™ acquisition parameters for quantitative bioanalysis. Bioanalysis 2011, 3, 863.
39. Food and Drug Administration. Guidance for industry: bioanalytical method validation, 2001. Available:.
40. V. Shah, K. Midha, J. Findlay, H. Hill, J. Hulse, I. McGilveray, G. McKay, K. Miller, R. Patnaik, M. Powell, A. Tonelli, C. T. Viswanathan, A. Yacobi,. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res. 2000, 17, 1551.